Mark Wallace is dean of the graduate school at Vanderbilt University in Nashville, Tennessee.
Mark Wallace
Director of the Vanderbilt Brain Institute
From this contributor
We need precise measurements of sensory traits related to autism
Separating sensitivity to sensory stimuli from the response to the stimuli may help scientists understand the root cause of sensory traits in autistic people.
We need precise measurements of sensory traits related to autism
By
Mark Wallace
30 July 2019 | 5 min read
Timing is key to understanding sensory, social issues in autism
Individuals with autism have trouble reading social cues because their brains connect sights and sounds over unusually long periods of time.
Timing is key to understanding sensory, social issues in autism
By
Mark Wallace
9 August 2016 | 8 min read
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read